Pharmaceuticals

Afrezza Market 2026–2030: Forecasting Business Opportunities Ahead

March 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the afrezza market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Afrezza Market expected to reach by 2030?

The historical surge can be linked to the escalating prevalence of diabetes, the inherent constraints of injectable insulin, the regulatory authorization of inhaled insulin, the patient-driven need for more accessible treatments, and its swift integration into adult diabetes management.

The anticipated expansion during the forecast period is fueled by an increasing prevalence of type 2 diabetes, greater acceptance of inhalation as a drug delivery method, the inclusion of broader patient groups, advancements in pulmonary safety data, and heightened awareness among physicians.

Significant trends expected within the forecast timeframe involve the growing integration of inhaled insulin treatments, an increasing preference for non-injectable diabetes management solutions, a stronger focus on controlling glucose levels after meals, the proliferation of rapid-acting insulin options, and enhanced patient adherence due to convenience.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19863&type=smp

What Drivers Are Driving Adoption Within The Afrezza Market?

The growing occurrence of diabetes is anticipated to boost the expansion of the afrezza market in the future. This condition is a long-term metabolic ailment marked by elevated blood glucose levels, caused by either inadequate insulin creation, poor insulin function, or a combination of both. The rise in diabetes cases stems from growing obesity rates, inactive lifestyles, poor dietary choices, an older demographic, increasing urbanization, genetic susceptibility, and enhanced detection and recognition of the disease. Afrezza plays a vital role in managing diabetes by rapidly moderating post-meal blood sugar surges, thereby averting complications and facilitating efficient glucose control. An example highlighting this trend is from March 2024, when the Office for Health Improvement and Disparities, a UK-based government department, reported that in March 2023, the proportion of individuals with type 1 diabetes in England undergoing 8 specific care processes at GP practices participating in the NDA increased to 43.8%, an increment from 35.2% in 2022. Consequently, the growing prevalence of diabetes is a key stimulant for the afrezza market.

What Segments Are Included Within The Afrezza Market?

The afrezza market covered in this report is segmented –

1) By Indication: Type 1 Diabetes, Type 2 Diabetes

2) By Distribution Channel: Hospitals And Clinics, Retail Pharmacies, Specialty Pharmacies

3) By End User: Adult Patients, Geriatric Patients

How Are Emerging Trends Affecting The Progression Of The Afrezza Market?

Leading companies in the Afrezza market are concentrating on developing technologically advanced products through comprehensive studies concerning the product and diabetes. Afrezza is utilized to manage Type 1 Diabetes using insulin inhalers. For instance, in June 2023, MannKind Corporation, a US-based biopharmaceutical company, commenced the INHALE-3 study, a clinical trial devised to address a crucial unmet need for adults with Type 1 Diabetes. The trial spans 17 weeks and incorporates a 13-week extension phase, allowing researchers to further evaluate outcomes over an extended period. INHALE-3 is a randomized, controlled study aimed at assessing innovative treatment approaches that could improve daily disease management and overall patient well-being. By initiating this trial, MannKind seeks to generate meaningful clinical insights that may support more effective therapeutic options for individuals living with Type 1 Diabetes.

Who Are The Prominent Global Companies Shaping The Afrezza Market Landscape?

Major companies operating in the afrezza market are Mannkind Corporation

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/afrezza-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Afrezza Market?

North America was the largest region in the afrezza market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the afrezza market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Afrezza Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19863&type=smp

Browse Through More Reports Similar to the Global Afrezza Market 2026, By The Business Research Company

Financial Analytics Market Report 2026

https://www.thebusinessresearchcompany.com/report/financial-analytics-global-market-report

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Trade Finance Market Report 2026

https://www.thebusinessresearchcompany.com/report/trade-finance-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795